Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Anti-p75 mAb did not inhibit either lytic function or cell proliferation mediated by anti-CD3 mAb, suggesting that only the high affinity IL-2R (p55 plus p75) is involved in anti-CD3 mediated cell activation in LDGL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP601396.RAUyaf1tlrZ_G-fS7eQ-w0xxFimbsBct5-B5GI3nT0qFU130_assertion description "[Anti-p75 mAb did not inhibit either lytic function or cell proliferation mediated by anti-CD3 mAb, suggesting that only the high affinity IL-2R (p55 plus p75) is involved in anti-CD3 mediated cell activation in LDGL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP601396.RAUyaf1tlrZ_G-fS7eQ-w0xxFimbsBct5-B5GI3nT0qFU130_provenance.
• NP740067.RAbN31Gjpich7QEYLaRP26P_axy0FzjlbVo7KR-8ngKSQ130_assertion description "[Anti-p75 mAb did not inhibit either lytic function or cell proliferation mediated by anti-CD3 mAb, suggesting that only the high affinity IL-2R (p55 plus p75) is involved in anti-CD3 mediated cell activation in LDGL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740067.RAbN31Gjpich7QEYLaRP26P_axy0FzjlbVo7KR-8ngKSQ130_provenance.
• NP168822.RAYizHqtsewe3N9FzHABJTzfTkL2GtiMg46ijaCULd53w130_assertion description "[Anti-p75 mAb did not inhibit either lytic function or cell proliferation mediated by anti-CD3 mAb, suggesting that only the high affinity IL-2R (p55 plus p75) is involved in anti-CD3 mediated cell activation in LDGL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP168822.RAYizHqtsewe3N9FzHABJTzfTkL2GtiMg46ijaCULd53w130_provenance.
• NP394664.RABwxNeaQy-sIof8srRko0mF1v7BnEQ5F77U9s6o9ncXA130_assertion description "[Anti-p75 mAb did not inhibit either lytic function or cell proliferation mediated by anti-CD3 mAb, suggesting that only the high affinity IL-2R (p55 plus p75) is involved in anti-CD3 mediated cell activation in LDGL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP394664.RABwxNeaQy-sIof8srRko0mF1v7BnEQ5F77U9s6o9ncXA130_provenance.
• NP483621.RABo6CPHu-yhIZAbxSWglUWGW_8B2DZy8cPBBxcCdygWU130_assertion description "[Anti-p75 mAb did not inhibit either lytic function or cell proliferation mediated by anti-CD3 mAb, suggesting that only the high affinity IL-2R (p55 plus p75) is involved in anti-CD3 mediated cell activation in LDGL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP483621.RABo6CPHu-yhIZAbxSWglUWGW_8B2DZy8cPBBxcCdygWU130_provenance.
• NP533751.RACkmKwkMRbwjKSLs7LsxaOVkKrnkboPNd1mCuUwIL4O4130_assertion description "[Anti-p75 mAb did not inhibit either lytic function or cell proliferation mediated by anti-CD3 mAb, suggesting that only the high affinity IL-2R (p55 plus p75) is involved in anti-CD3 mediated cell activation in LDGL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP533751.RACkmKwkMRbwjKSLs7LsxaOVkKrnkboPNd1mCuUwIL4O4130_provenance.
• NP712572.RAD0e63XGxmJm5o-pBj-VL4rnELSDMzB31uBsYssMvnf8130_assertion description "[Anti-p75 mAb did not inhibit either lytic function or cell proliferation mediated by anti-CD3 mAb, suggesting that only the high affinity IL-2R (p55 plus p75) is involved in anti-CD3 mediated cell activation in LDGL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712572.RAD0e63XGxmJm5o-pBj-VL4rnELSDMzB31uBsYssMvnf8130_provenance.
• NP378924.RAZmhaKTNmMX7uUb216VeNhePW9o4sdhw7Ji2xG0uf6rU130_assertion description "[Anti-p75 mAb did not inhibit either lytic function or cell proliferation mediated by anti-CD3 mAb, suggesting that only the high affinity IL-2R (p55 plus p75) is involved in anti-CD3 mediated cell activation in LDGL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378924.RAZmhaKTNmMX7uUb216VeNhePW9o4sdhw7Ji2xG0uf6rU130_provenance.
• NP606001.RA1nBCb5I45EOlPahU3cSNjG6BOG3ZGSa2--oEr5fe3jM130_assertion description "[Anti-p75 mAb did not inhibit either lytic function or cell proliferation mediated by anti-CD3 mAb, suggesting that only the high affinity IL-2R (p55 plus p75) is involved in anti-CD3 mediated cell activation in LDGL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP606001.RA1nBCb5I45EOlPahU3cSNjG6BOG3ZGSa2--oEr5fe3jM130_provenance.
• NP659915.RAp2u0KjQH6j6wLkI2QUqwpea9QiL-1_tcoi0taaKFaRw130_assertion description "[Anti-p75 mAb did not inhibit either lytic function or cell proliferation mediated by anti-CD3 mAb, suggesting that only the high affinity IL-2R (p55 plus p75) is involved in anti-CD3 mediated cell activation in LDGL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP659915.RAp2u0KjQH6j6wLkI2QUqwpea9QiL-1_tcoi0taaKFaRw130_provenance.
• NP707560.RAHWdfaMSkYQ2dAY7WzQZcBTaztxfpz-5hzVIhefYem4o130_assertion description "[Anti-p75 mAb did not inhibit either lytic function or cell proliferation mediated by anti-CD3 mAb, suggesting that only the high affinity IL-2R (p55 plus p75) is involved in anti-CD3 mediated cell activation in LDGL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP707560.RAHWdfaMSkYQ2dAY7WzQZcBTaztxfpz-5hzVIhefYem4o130_provenance.
• NP493226.RArKVgrY0sWlmBYv06N5lL6eWTs0UFj8nlEEaS4TdRjoI130_assertion description "[Anti-p75 mAb did not inhibit either lytic function or cell proliferation mediated by anti-CD3 mAb, suggesting that only the high affinity IL-2R (p55 plus p75) is involved in anti-CD3 mediated cell activation in LDGL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493226.RArKVgrY0sWlmBYv06N5lL6eWTs0UFj8nlEEaS4TdRjoI130_provenance.
• NP661874.RAyZsJ7vrUGrPGefFSGxk_wNRGWFFEdIwLvCMub6CIbLQ130_assertion description "[Anti-p75 mAb did not inhibit either lytic function or cell proliferation mediated by anti-CD3 mAb, suggesting that only the high affinity IL-2R (p55 plus p75) is involved in anti-CD3 mediated cell activation in LDGL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP661874.RAyZsJ7vrUGrPGefFSGxk_wNRGWFFEdIwLvCMub6CIbLQ130_provenance.